November 20, 2024
WE-REACH Supported SoundBubble Team Wins $100k Infosys Prize
WE-REACH is proud to announce that the currently supported SoundBubble team has won a $100k Infosys prize for their SoundBubble hearing aid, while the larger concept of AI headphones has been featured in Nature Electronics. For more information, see the following stories at: Geekwire UW Today
October 30, 2024
WE-REACH Alum, Archon Biosciences Secures $20M in Financing
WE-REACH is proud to announce that project alumni James Lazarovits and George Ueda have launched their startup, Archon Biosciences, with $20M in seed financing to advance their AI-drive Antibody Cage (AbC) technology to unlock new therapeutic targets. The team leverages technology from the University of Washington Institute for Protein Design (IPD), which was recognized earlier…
October 9, 2024
Dr. Baker Awarded Nobel Prize in Chemistry
Congratulations to David Baker of the University of Washington; he is one of the 2024 Nobel Laureates in Chemistry. Dr. Baker serves on the Executive Committee of the UW WE-REACH leadership team. For more information, follow the link to the Nobel Prize Announcement: link.
May 22, 2024
Summer Funding Announcement – 2024
WE-REACH is pleased to announce plans for an upcoming Summer 2024 Research Funding Announcement! Stay tuned for more information on Friday 5/24!
January 17, 2024
UM and UW Partner to Create SIHI-REACH, an NIH-Designated Entrepreneurial Hub for the PNW
(Seattle, WA)— The National Institutes of Health (NIH) has chosen the University of Montana’s L.S. Skaggs Institute of Health Innovation as the new Pacific Northwest location for one of five entrepreneurial hubs across the United States. Dubbed SIHI-REACH, this hub will support academic innovators across the WWAMI region in Washington, Wyoming, Alaska, Montana, and Idaho….
August 10, 2022
A Paradigm Shift in Medical Tape
It all began with a bad experience. Isn’t that the catalyst for most innovations? Professor Eric Seibel, a UW researcher in Mechanical Engineering and practical problem-solver, was by the bedside of his young son who had fallen out of a tree and ended up in Seattle Children’s Hospital with cracked ribs. During his treatment, Seibel’s…
July 12, 2022
WE-REACH Supports Institute for Protein Design Spinouts
WE-REACH is proud to support spinouts from the UW Institute for Protein Design (IPD) including Anindya Roy’s Lila Biologics, Stephanie Berger’s Mopac Bio, and George Ueda and James Lazarovits Tie2 super agonists project to treat acute respiratory distress syndrome and sepsis. For more information, see Charlotte Schubert’s latest article in Geekwire.
May 2, 2022
Roy Wins WE-REACH Go-To-Market Award for Novel Drug to Treat Idiopathic Pulmonary Fibrosis (IPF)
Seattle, WA (May 2, 2022)—The Washington Entrepreneurial Research Evaluation and Commercialization Hub (WE-REACH) is pleased to announce a product concept award for Dr. Anindya Roy and his team at the UW Medicine Institute for Protein Design, including Drs. Jake Kraft and Hua Bai. They are developing a novel binder protein in an aerosolized delivery system…
February 1, 2022
Healing Hands: WE-REACH Helps Fund Game-Changing Hand Injury Treatment, ReHeal
Serious hand and finger injuries provided the impetus for three individual innovators to connect, collaborate, and investigate over the past 10 years. The result is a promising prototype device called the ReHeal Glove, which will be pilot tested with patients in the next few months using a combination of funding and support from WE-REACH (the…
November 11, 2021
$14.9M Awarded to Lutz Lab’s COVID-19 Technology Company
Anavasi Diagnostics, a company recently founded out of Professor Barry Lutz’s lab at the University of Washington, announced it has been awarded $14.9 million from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADxSM) initiative. The funding will accelerate the launch and broad market availability of the AscencioDx™ molecular diagnostic platform for the detection of RNA indicative…